

Is a New At-Home Colon Cancer Test for you? New article quotes Dr. Rudert!
In an article excerpt of July 27, 2017 by Matt Smith, WebMD (reviewed by Michael W Smith, MD): "Up to 40% of people who should get a test for colon cancer aren't doing so.That's one of the reasons why some doctors are encouraged by Cologuard, a new at-home test for colon cancer." Read the excerpt of the article below to see what Dr. Rudert has to say about the possible benefits of the new at-home colon cancer test, Cologuard. The mail-away DNA stool test for colon cancer is


Exact Sciences has revolutionized NON-INVASIVE colon cancer testing! Watch Cutting Edge NEW video wi
4 out of 10 eligible people are not being screened for colon cancer with colonoscopy. An easy stool DNA test, Cologuard by Exact Sciences is now available. Please share this groundbreaking, life-saving news and video! Video host is Kevin Conroy, CEO of Exact Sciences with featured guest, Dr. Cynthia Rudert. #coloncancertest #Cologuard #noninvasivecoloncancertest #coloncancerDNAtest #athomecoloncancertest


WSB-TV Atlanta Channel 2 reporter Wendy Corona with Dr. Rudert: Medical Breakthrough! At-home colon
WSB TV Atlanta Channel 2 reporter Wendy Corona with Dr. Cynthia Rudert, Atlanta gastroenterologist, reports on medical breakthrough: new at-home colon cancer test Cologuard! For more information about this life-changing test see excerpt below. Cologuard is now covered for all Medicare patients as described in the CMS national Coverage decision released on October 9, 2014. ATLANTA Financial analyst Marja Robinson is busy. She felt she didn't have the time, nor the desire to


New Non-Invasive At Home Test Kit for Colon Cancer - Cologuard!
Dr. Cynthia Rudert, Celiac Disease and Gluten Intolerance expert brings to you the newest buzz on colon cancer testing - Cologuard, the new non-invasive at home test for colon cancer! Look no further for the latest information! What is Cologuard? Dr. Rudert answers: Cologuard is the new FDA approved noninvasive test for colon cancer screening. Cologuard was co-developed by Exact Sciences and the Mayo Clinic and is now available by prescription. It analyzes stool based DNA an